Drugs for Villous Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 6)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Cianidanol |
Approved, Withdrawn |
Phase 2 |
|
154-23-4 |
9064 |
Synonyms:
(-)-Epicatechin
(+)-(2R,3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol
(+)-(2R:3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol
(+)-(2R:3S)-5,7,3’,4’-Tetrahydroxyflavan-3-ol
(+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol
(+)-3’,4’,5,7-Tetrahydroxy-2,3-trans-flavan-3-ol
(+)-Catechin
(+)-Catechin hydrate
(+)-Catechol
(+)-Cianidanol
(+)-Cyanidan-3-ol
(+)-Cyanidanol
(+)-Cyanidanol-3
(+/-)-catechin
(+/-)-catechin hydrate
(2R,3S)-(+)-Catechin
(2R,3S)-Catechin
(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
3,3',4',5,7-Flavanpentol
Acid, catechinic
Acid, catechuic
Biocatechin
CATECHIN
Catechinate
|
Catechinic acid
Catechuate
Catechuic acid
Catergen
Cianidanol
Cianidanolum
Cianidol
Cyanidanol
Cyanidanol 3
Cyanidanol-3
Cyanidol
D-(+)-Catechin
D-Catechin
D-Catechol
Dexcyanidanol
Epicatechin
KB 53
KB-53
trans-(+)-3,3',4',5,7-Flavanpentol
trans-(+)-3,3’,4’,5,7-Flavanpentol
trans3,3,4,5,7 Pentahydroxyflavane
YK-85 light yellow powder 85
Zyma
|
|
2 |
|
Epigallocatechin gallate |
Investigational |
Phase 2 |
|
989-51-5 |
65064 |
Synonyms:
(-)-Epigallocatechin gallat
(-)-EPIGALLOCATECHIN GALLATE
(-)-EPIGALLOCATECHIN-3-O-GALLATE
(-)-Epigallocatechin-3-O-gallic acid
(-)-Epigallocatechol gallate
(-)-Epigallocatehin gallate
[(2R,3R)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-CHROMEN-3-YL] 3,4,5-TRIHYDROXYBENZOATE
[(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoic acid
Catechin deriv.
egcg
EGCG CPD
EGCG|epigallocatechin gallate
Epigallocatcchin gallate
Epigallocate
|
Epigallocatechin 3-gallate
Epigallocatechin 3-gallic acid
Epigallo-catechin gallate
EPIGALLOCATECHIN GALLATE
EPIGALLOCATECHIN GALLATE,EGCG
Epigallocatechin gallic acid
Epigallocatechin-3-gallate
Epigallocatechin-3-O-gallate
Epigallocic acid
EPIGALOCATECHIN GALLATE
Galloyl-L-epigallocatechol
Sunphenon
Tea catechin
|
|
3 |
|
Epigallocatechin |
Experimental, Investigational |
Phase 2 |
|
970-74-1 |
72277 |
Synonyms:
(-)-3,3',4',5,5',7-Flavanhexol
(-)-3,3’,4’,5,5’,7-Flavanhexol
(-)-cis-3,3',4',5,5',7-Hexahydroxyflavan
(-)-cis-3,3',4',5,5',7-Hexahydroxyflavane
(−)-epigallocatechin
(-)-epi-Gallocatechin
(-)-Epigallocatechin
(-)-Epigallocatechol
(2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
(2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,5,7-trihydroxychroman
(2R,3R)-3,4-Dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol
1-epi-3',4',5',5,7-Pentahydroxy-3-flavanol
1-epi-3’,4’,5’,5,7-Pentahydroxy-3-flavanol
2,3-cis-Epigallocatechin
|
3,3',4',5,5',7-Flavanhexol
3,3’,4’,5,5’,7-Flavanhexol
Antiscurvy factor C2
EGC
epi-Gallocatechin
Epigallocatechin
Epigallocatechol
Gallocatechin
Gallocatechol
Gallocatechol, (2R-cis)-isomer
Gallocatechol, (2R-trans)-isomer
Galloepicatechin
L-Epigallocatechin
l-Epigallocatechol
|
|
4 |
|
Epicatechin |
Investigational |
Phase 2 |
|
490-46-0 |
58571364 72276 |
Synonyms:
(-)-Epicatechin
(-)-Epicatechol
(+)-Catechin
(+)-Cyanidanol
(+)-Cyanidanol-3
(2R,3R)-(-)-Epicatechin
3,3',4',5,7-Flavanpentol
3,3',4',5,7-Pentahydroxyflavane
Acid, catechinic
Acid, catechuic
alpha-Catechin
Catechin
Catechinic acid
Catechuic acid
Catergen
Cianidanol
Cyanidanol 3
|
Cyanidanol-3
EC
Epicatechin
Epi-catechin
Epicatechin-(2a->7,4a->8)-epicatechin 3-galactoside
Epicatechin-(2α->7,4α->8)-epicatechin 3-galactoside
Epicatechol
Epigallocatechin
KB 53
KB-53
L(-)-Epicatechin
L-Acacatechin
L-Epicatechin
L-Epicatechol
NSC-81161
Zyma
|
|
5 |
|
Cola |
|
Phase 2 |
|
|
|
6 |
|
Tea |
|
Phase 2 |
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE- |
Completed |
NCT01360320 |
Phase 2 |
|
2 |
Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Duodenum and Ampulla |
Recruiting |
NCT02306603 |
|
|
3 |
Outcomes of Endoscopic Resection in the Upper Gastrointestinal Tract |
Recruiting |
NCT02305290 |
|
|
4 |
Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach. |
Recruiting |
NCT02306707 |
|
|
|